Gene expression testing helps determine chemotherapy needs for hormone receptor-positive breast cancer, optimizing treatment ...
Hosted on MSN2mon
Approved drug dronedarone found to inhibit the proliferation of esophageal squamous cell carcinomaFurther investigation into the role of CDK4/CDK6 in ESCC was conducted through CRISPR-mediated gene knockout experiments. The depletion of CDK4/CDK6 in ESCC cells not only reduced their ...
New agents targeting endocrine therapy and CDK4/6 resistance in hormone receptor–positive breast cancer are in development.
Dr. Sara M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer. At the 42nd Annual Miami Breast Cancer Conference, Dr. Sara M. Tolaney sat down for ...
Hosted on MSN3mon
Machine learning model predicts breast cancer treatment responseWhile the use of CDK4/6 inhibitors combined with endocrine ... a test designed to detect gene mutations and match patients to treatments or clinical trials for actionable cancer targets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback